GlassScriptPhysician profile
Johnny M Chua
NPI 1891269734
$2,990.72
in general payments reported to CMS, 2019-2025
34 companies · $935 in 2025
The $935 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.82 · 2022: $345 · 2023: $1,207 · 2024: $404 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,545.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $439.67 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kerecis Limited | $402.62 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Astrazeneca Pharmaceuticals LP | $326.92 | 2023-2025 | Andexxa, Brilinta, Imfinzi |
| Abiomed | $301.38 | 2023-2024 | Impella |
| Medtronic, INC. | $278.79 | 2022-2025 | Endurant Iis, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $169.30 | 2022-2025 | Hemosphere, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Getinge USA Sales, LLC | $99.82 | 2021 | |
| La Jolla Pharmaceutical Company | $99.80 | 2022-2025 | Giapreza |
| Cvrx, INC. | $71.85 | 2023-2025 | Barostim Neo System |
| Goode Surgical INC | $56.39 | 2023 | |
| Philips North America LLC | $53.84 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Bolton Medical INC | $53.12 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Merck Sharp & Dohme LLC | $52.42 | 2023-2025 | Keytruda |
| Aroa Biosurgery Incorporated | $48.23 | 2025 | |
| Becton, Dickinson and Company | $48.14 | 2025 | Acumen Iq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $45.57 | 2023-2024 | Aliya System |
| Lsi Solutions INC | $42.68 | 2022 | |
| Avita Medical Americas, LLC | $41.57 | 2025 | Recell, Cohealyx, Permeaderm |
| W. L. Gore & Associates, INC. | $35.26 | 2022-2023 | Gore Tag Conformable Thoracic Endoprosthesis |
| Stryker Corporation | $32.17 | 2022-2023 | Na |
| Ethicon US, LLC | $31.80 | 2025 | Vistaseal |
| Organogenesis INC. | $27.34 | 2023 | Puraply |
| Clearflow INC. | $26.80 | 2025 | Pleuraflow System With Flowglide |
| Abbott Laboratories | $24.18 | 2024 | Portico |
| Amgen INC. | $23.81 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.61 | 2023 | Camzyos |
| Acera Surgical, INC. | $21.13 | 2025 | Restrata Wound Matrix |
| Davol INC. | $21.11 | 2025 | Progel Applicator Spray Tips |
| Chiesi USA, INC. | $19.56 | 2023 | Cleviprex |
| Kci USA, INC. | $16.92 | 2023 | Prevena |
| Octapharma USA, INC. | $15.04 | 2025 | Fibryga |
| Amarin Pharma, INC. | $14.70 | 2022 | |
| Olympus America INC. | $14.09 | 2023 | |
| Silk Road Medical, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.